Table of Contents Europe Tuberculosis Drugs Market Report 2012-2023 1 Tuberculosis Drugs Overview 1.1 Product Overview and Scope of Tuberculosis Drugs 1.2 Classification of Tuberculosis Drugs by Product Category 1.2.1 Europe Tuberculosis Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Tuberculosis Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 First-line Anti-TB Drugs 1.2.4 Second-line Anti-TB Drugs 1.3 Europe Tuberculosis Drugs Market by Application/End Users 1.3.1 Europe Tuberculosis Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 New Patients 1.3.3 Drug Resistant TB Patients 1.4 Europe Tuberculosis Drugs Market by Region 1.4.1 Europe Tuberculosis Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Tuberculosis Drugs (2012-2023) 1.5.1 Europe Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Tuberculosis Drugs 2.2 Raw Material Analysis of Tuberculosis Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Tuberculosis Drugs 2.4 Other Costs Analysis of Tuberculosis Drugs 2.5 Manufacturing Cost Structure Analysis of Tuberculosis Drugs 2.6 Manufacturing Process Analysis of Tuberculosis Drugs 2.7 Raw Materials Sources of Tuberculosis Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Tuberculosis Drugs Players/Suppliers Profiles and Sales Data 3.1 Sanofi 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Tuberculosis Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Sanofi Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Sanofi Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Sanofi Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.2 Pfizer 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Tuberculosis Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Pfizer Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Pfizer Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Pfizer Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.3 Janssen Products 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Tuberculosis Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Janssen Products Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Janssen Products Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Janssen Products Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.4 Otsuka 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Tuberculosis Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Otsuka Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Otsuka Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Otsuka Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.5 AstraZeneca 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Tuberculosis Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 AstraZeneca Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 AstraZeneca Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 AstraZeneca Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.6 Lupin Pharmaceuticals 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Tuberculosis Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Lupin Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Lupin Pharmaceuticals Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Lupin Pharmaceuticals Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.7 Akorn 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Tuberculosis Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Akorn Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Akorn Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Akorn Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.8 STI Pharma 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Tuberculosis Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 STI Pharma Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 STI Pharma Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 STI Pharma Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.9 Sandoz 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Tuberculosis Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Sandoz Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Sandoz Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Sandoz Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.10 Labatec Pharma SA 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Tuberculosis Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Labatec Pharma SA Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Labatec Pharma SA Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Labatec Pharma SA Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.11 Archivel Farma 3.12 BioMerieux 3.13 Cepheid 3.14 Epistem 4 Europe Tuberculosis Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Tuberculosis Drugs Market Competition by Players/Manufacturers 4.1.1 Europe Tuberculosis Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Tuberculosis Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Tuberculosis Drugs Sales and Revenue by Type 4.2.1 Europe Tuberculosis Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Tuberculosis Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Tuberculosis Drugs Sales and Revenue by Application 4.3.1 Europe Tuberculosis Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Tuberculosis Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Tuberculosis Drugs Sales (K Units) by Application 5 Germany Tuberculosis Drugs (Sales, Revenue and Price) 5.1 Germany Tuberculosis Drugs Sales and Value (2012-2017) 5.1.1 Germany Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Germany Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Tuberculosis Drugs Sales (K Units) and Market Share by Type 5.3 Germany Tuberculosis Drugs Sales (K Units) and Market Share by Application 6 UK Tuberculosis Drugs (Sales, Revenue and Price) 6.1 UK Tuberculosis Drugs Sales and Value (2012-2017) 6.1.1 UK Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 6.1.3 UK Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Tuberculosis Drugs Sales (K Units) and Market Share by Type 6.3 UK Tuberculosis Drugs Sales (K Units) and Market Share by Application 7 France Tuberculosis Drugs (Sales, Revenue and Price) 7.1 France Tuberculosis Drugs Sales and Value (2012-2017) 7.1.1 France Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 7.1.3 France Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Tuberculosis Drugs Sales (K Units) and Market Share by Type 7.3 France Tuberculosis Drugs Sales (K Units) and Market Share by Application 8 Russia Tuberculosis Drugs (Sales, Revenue and Price) 8.1 Russia Tuberculosis Drugs Sales and Value (2012-2017) 8.1.1 Russia Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Russia Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Tuberculosis Drugs Sales (K Units) and Market Share by Type 8.3 Russia Tuberculosis Drugs Sales (K Units) and Market Share by Application 9 Benelux Tuberculosis Drugs (Sales, Revenue and Price) 9.1 Benelux Tuberculosis Drugs Sales and Value (2012-2017) 9.1.1 Benelux Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Tuberculosis Drugs Sales (K Units) and Market Share by Type 9.3 Benelux Tuberculosis Drugs Sales (K Units) and Market Share by Application 10 Italy Tuberculosis Drugs (Sales, Revenue and Price) 10.1 Italy Tuberculosis Drugs Sales and Value (2012-2017) 10.1.1 Italy Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Italy Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Tuberculosis Drugs Sales (K Units) and Market Share by Type 10.3 Italy Tuberculosis Drugs Sales (K Units) and Market Share by Application 11 Spain Tuberculosis Drugs (Sales, Revenue and Price) 11.1 Spain Tuberculosis Drugs Sales and Value (2012-2017) 11.1.1 Spain Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Spain Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Tuberculosis Drugs Sales (K Units) and Market Share by Type 11.3 Spain Tuberculosis Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Tuberculosis Drugs Market Forecast (2018-2023) 13.1 Europe Tuberculosis Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Tuberculosis Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Tuberculosis Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Tuberculosis Drugs Price and Trend Forecast (2018-2023) 13.2 Europe Tuberculosis Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Tuberculosis Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Tuberculosis Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Tuberculosis Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Tuberculosis Drugs Sales Forecast by Type (2018-2023) 13.3.2 Europe Tuberculosis Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Europe Tuberculosis Drugs Price Forecast by Type (2018-2023) 13.4 Europe Tuberculosis Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Tuberculosis Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Tuberculosis Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Tuberculosis Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Tuberculosis Drugs Table Europe Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Tuberculosis Drugs Sales (K Units) Market Share by Types in 2017 Figure First-line Anti-TB Drugs Picture Figure Second-line Anti-TB Drugs Picture Table Europe Tuberculosis Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Tuberculosis Drugs by Applications in 2017 Figure New Patients Picture Figure Drug Resistant TB Patients Picture Table Europe Market Tuberculosis Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure France Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Europe Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Tuberculosis Drugs Table Industry News List of Tuberculosis Drugs Figure Industry Chain Structure of Tuberculosis Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Tuberculosis Drugs in 2017 Figure Manufacturing Process Analysis of Tuberculosis Drugs Table Raw Materials Sources of Tuberculosis Drugs Major Manufacturers Europe Table Major Buyers of Tuberculosis Drugs Table Sanofi Basic Information List Table Sanofi Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Sanofi Tuberculosis Drugs Sales Europe Market Share (%) (2012-2017) Figure Sanofi Tuberculosis Drugs Revenue Europe Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi Tuberculosis Drugs Volume in New Patients and Its Application Share Table Sanofi Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Sanofi Tuberculosis Drugs Volume in and Its Application Share Table Pfizer Basic Information List Table Pfizer Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Pfizer Tuberculosis Drugs Sales Europe Market Share (%) (2012-2017) Figure Pfizer Tuberculosis Drugs Revenue Europe Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Tuberculosis Drugs Volume in New Patients and Its Application Share Table Pfizer Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Pfizer Tuberculosis Drugs Volume in and Its Application Share Table Janssen Products Basic Information List Table Janssen Products Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Products Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Janssen Products Tuberculosis Drugs Sales Europe Market Share (%) (2012-2017) Figure Janssen Products Tuberculosis Drugs Revenue Europe Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Products Tuberculosis Drugs Volume in New Patients and Its Application Share Table Janssen Products Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Janssen Products Tuberculosis Drugs Volume in and Its Application Share Table Otsuka Basic Information List Table Otsuka Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Otsuka Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Otsuka Tuberculosis Drugs Sales Europe Market Share (%) (2012-2017) Figure Otsuka Tuberculosis Drugs Revenue Europe Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Otsuka Tuberculosis Drugs Volume in New Patients and Its Application Share Table Otsuka Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Otsuka Tuberculosis Drugs Volume in and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Tuberculosis Drugs Sales Europe Market Share (%) (2012-2017) Figure AstraZeneca Tuberculosis Drugs Revenue Europe Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Tuberculosis Drugs Volume in New Patients and Its Application Share Table AstraZeneca Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table AstraZeneca Tuberculosis Drugs Volume in and Its Application Share Table Lupin Pharmaceuticals Basic Information List Table Lupin Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Lupin Pharmaceuticals Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Lupin Pharmaceuticals Tuberculosis Drugs Sales Europe Market Share (%) (2012-2017) Figure Lupin Pharmaceuticals Tuberculosis Drugs Revenue Europe Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Lupin Pharmaceuticals Tuberculosis Drugs Volume in New Patients and Its Application Share Table Lupin Pharmaceuticals Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Lupin Pharmaceuticals Tuberculosis Drugs Volume in and Its Application Share Table Akorn Basic Information List Table Akorn Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Akorn Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Akorn Tuberculosis Drugs Sales Europe Market Share (%) (2012-2017) Figure Akorn Tuberculosis Drugs Revenue Europe Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Akorn Tuberculosis Drugs Volume in New Patients and Its Application Share Table Akorn Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Akorn Tuberculosis Drugs Volume in and Its Application Share Table STI Pharma Basic Information List Table STI Pharma Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure STI Pharma Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure STI Pharma Tuberculosis Drugs Sales Europe Market Share (%) (2012-2017) Figure STI Pharma Tuberculosis Drugs Revenue Europe Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table STI Pharma Tuberculosis Drugs Volume in New Patients and Its Application Share Table STI Pharma Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table STI Pharma Tuberculosis Drugs Volume in and Its Application Share Table Sandoz Basic Information List Table Sandoz Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sandoz Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Sandoz Tuberculosis Drugs Sales Europe Market Share (%) (2012-2017) Figure Sandoz Tuberculosis Drugs Revenue Europe Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sandoz Tuberculosis Drugs Volume in New Patients and Its Application Share Table Sandoz Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Sandoz Tuberculosis Drugs Volume in and Its Application Share Table Company Labatec Pharma SA Basic Information List Table Company Labatec Pharma SA Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Labatec Pharma SA Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Company Labatec Pharma SA Tuberculosis Drugs Sales Europe Market Share (%) (2012-2017) Figure Company Labatec Pharma SA Tuberculosis Drugs Revenue Europe Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Labatec Pharma SA Tuberculosis Drugs Volume in New Patients and Its Application Share Table Company Labatec Pharma SA Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Company Labatec Pharma SA Tuberculosis Drugs Volume in and Its Application Share Table Europe Tuberculosis Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Tuberculosis Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Tuberculosis Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Tuberculosis Drugs Sales Share by Players/Manufacturers Table Europe Tuberculosis Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Tuberculosis Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Tuberculosis Drugs Revenue Market Share (%) Players Figure 2017 Europe Tuberculosis Drugs Revenue Market Share (%) Players Table Europe Tuberculosis Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Tuberculosis Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Tuberculosis Drugs by Type (2012-2017) Figure Europe Tuberculosis Drugs Sales Growth Rate (%) by Type (2012-2017) Table Europe Tuberculosis Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Tuberculosis Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Tuberculosis Drugs by Type (2012-2017) Figure Europe Tuberculosis Drugs Revenue Growth Rate by Type (2012-2017) Table Europe Tuberculosis Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Tuberculosis Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Tuberculosis Drugs by Regions (2012-2017) Figure Europe Tuberculosis Drugs Sales Market Share by Regions in 2017 Table Europe Tuberculosis Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Tuberculosis Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Tuberculosis Drugs by Regions (2012-2017) Figure Europe Tuberculosis Drugs Revenue Market Share by Regions in 2017 Table Europe Tuberculosis Drugs Sales (K Units) and Market Share by Application (2012-2017) Table Europe Tuberculosis Drugs Sales Share (%) by Application (2012-2017) Figure Europe Tuberculosis Drugs Sales Market Share by Application (2012-2017) Figure Europe Tuberculosis Drugs Sales Market Share by Application (2012-2017) Figure Germany Tuberculosis Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Germany Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Germany Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Germany Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Germany Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Germany Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure UK Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure UK Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table UK Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table UK Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure UK Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table UK Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table UK Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure UK Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure France Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure France Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table France Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table France Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure France Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table France Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table France Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure France Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure Russia Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Russia Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Russia Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Russia Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Russia Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Russia Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Russia Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure Italy Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Italy Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Italy Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Italy Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Italy Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Italy Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Italy Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure Benelux Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Benelux Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Benelux Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Benelux Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure Spain Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Spain Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Spain Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Spain Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Spain Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Spain Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Spain Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Tuberculosis Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Tuberculosis Drugs Price and Trend Forecast (2018-2023) Table Europe Tuberculosis Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Tuberculosis Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Tuberculosis Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Tuberculosis Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Tuberculosis Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Tuberculosis Drugs Revenue Market Share Forecast by Regions in 2023 Figure Germany Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Tuberculosis Drugs Sales (K Units) Forecast by Type (2018-2023) Figure Europe Tuberculosis Drugs Sales Market Share Forecast by Type (2018-2023) Table Europe Tuberculosis Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Tuberculosis Drugs Revenue Market Share Forecast by Type (2018-2023) Table Europe Tuberculosis Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Tuberculosis Drugs Sales (K Units) Forecast by Application (2018-2023) Figure Europe Tuberculosis Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Sanofi Pfizer Janssen Products Otsuka AstraZeneca Lupin Pharmaceuticals Akorn STI Pharma Sandoz Labatec Pharma SA Archivel Farma BioMerieux Cepheid Epistem